降糖药-话题@MedSci

#降糖药#

178篇内容 | 4725人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1270845, encodeId=1d9112e084517, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：HIV感染 vs 非感染，口服降糖药的有效性研究, objectType=article, longId=77869, objectId=36dfe7869dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36dfe7869dd, replyNumber=0, likeNumber=54, createdTime=2016-09-21, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36dfe7869dd, moduleTitle=Diabetes Care：HIV感染 vs 非感染，口服降糖药的有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36dfe7869dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270939, encodeId=f52212e0939fa, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=十问十答，轻松掌握磺脲类降糖药！, objectType=article, longId=77506, objectId=e378e750622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e378e750622, replyNumber=0, likeNumber=158, createdTime=2016-09-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e378e750622, moduleTitle=十问十答，轻松掌握磺脲类降糖药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e378e750622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270844, encodeId=399212e084447, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=JASN:新型口服降糖药可帮助患者保护肾脏健康, objectType=article, longId=75684, objectId=d02ee56847c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02ee56847c, replyNumber=0, likeNumber=32, createdTime=2016-08-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02ee56847c, moduleTitle=JASN:新型口服降糖药可帮助患者保护肾脏健康, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d02ee56847c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270843, encodeId=fd3012e08430b, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=警惕！这些降糖药可引起贫血！, objectType=article, longId=75661, objectId=6cf3e5661ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf3e5661ea, replyNumber=0, likeNumber=69, createdTime=2016-08-24, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf3e5661ea, moduleTitle=警惕！这些降糖药可引起贫血！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf3e5661ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270842, encodeId=16fd12e084275, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=CFDA再次修订警告：这种降糖药可增加心衰风险！, objectType=article, longId=75217, objectId=39aee521758, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39aee521758, replyNumber=0, likeNumber=118, createdTime=2016-08-17, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39aee521758, moduleTitle=CFDA再次修订警告：这种降糖药可增加心衰风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39aee521758)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270841, encodeId=f22512e08418a, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=口服降糖药的作用为何越来越差, objectType=article, longId=74726, objectId=8ffbe472637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ffbe472637, replyNumber=0, likeNumber=81, createdTime=2016-08-10, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ffbe472637, moduleTitle=口服降糖药的作用为何越来越差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ffbe472637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270840, encodeId=60c012e0840a8, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=JAMA：看过来，2型糖尿病降糖药物疗效大PK, objectType=article, longId=73264, objectId=b67be3264be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67be3264be, replyNumber=0, likeNumber=99, createdTime=2016-07-21, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67be3264be, moduleTitle=JAMA：看过来，2型糖尿病降糖药物疗效大PK, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b67be3264be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270839, encodeId=636212e0839ed, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=重磅！勃林格-礼来降糖药Jardiance在确诊心血管疾病的2型糖尿病患者中显著延缓肾病进展风险, objectType=article, longId=71287, objectId=1c0be128701, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0be128701, replyNumber=0, likeNumber=74, createdTime=2016-06-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0be128701, moduleTitle=重磅！勃林格-礼来降糖药Jardiance在确诊心血管疾病的2型糖尿病患者中显著延缓肾病进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0be128701)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270835, encodeId=1da812e083520, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, objectType=article, longId=71031, objectId=ed04e103173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed04e103173, replyNumber=0, likeNumber=56, createdTime=2016-06-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed04e103173, moduleTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed04e103173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270836, encodeId=652812e08369c, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）, objectType=article, longId=71032, objectId=f516e10324f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f516e10324f, replyNumber=0, likeNumber=59, createdTime=2016-06-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f516e10324f, moduleTitle=ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f516e10324f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270837, encodeId=932c12e083758, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著, objectType=article, longId=71033, objectId=e336e1033ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e336e1033ae, replyNumber=0, likeNumber=66, createdTime=2016-06-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e336e1033ae, moduleTitle=ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e336e1033ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270838, encodeId=8b3b12e083864, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平, objectType=article, longId=71034, objectId=fefbe10347d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fefbe10347d, replyNumber=0, likeNumber=82, createdTime=2016-06-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fefbe10347d, moduleTitle=ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fefbe10347d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270834, encodeId=5fd912e083497, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=降糖药Jardiance缓解肾功能障碍, objectType=article, longId=70890, objectId=0101e089022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0101e089022, replyNumber=0, likeNumber=72, createdTime=2016-06-17, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0101e089022, moduleTitle=降糖药Jardiance缓解肾功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0101e089022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270832, encodeId=b66b12e083216, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, objectType=article, longId=69403, objectId=04f76940319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04f76940319, replyNumber=0, likeNumber=60, createdTime=2016-05-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04f76940319, moduleTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04f76940319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270833, encodeId=519712e0833f1, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药, objectType=article, longId=69405, objectId=846b694053d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=846b694053d, replyNumber=0, likeNumber=85, createdTime=2016-05-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=846b694053d, moduleTitle=本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=846b694053d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270831, encodeId=d16f12e0831bf, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=FDA批准强生降糖药INVOKAMET用于2型糖尿病一线治疗, objectType=article, longId=69333, objectId=9bb56933380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bb56933380, replyNumber=0, likeNumber=69, createdTime=2016-05-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bb56933380, moduleTitle=FDA批准强生降糖药INVOKAMET用于2型糖尿病一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bb56933380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270830, encodeId=6b9012e083000, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=教你搞定「各类口服降糖药」, objectType=article, longId=67830, objectId=707b6e83052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=707b6e83052, replyNumber=0, likeNumber=98, createdTime=2016-05-11, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=707b6e83052, moduleTitle=教你搞定「各类口服降糖药」, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=707b6e83052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270829, encodeId=4b8812e0829b2, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=这4种降糖药已被证实有心血管获益, objectType=article, longId=67461, objectId=6ef86e461d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ef86e461d7, replyNumber=0, likeNumber=56, createdTime=2016-05-05, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ef86e461d7, moduleTitle=这4种降糖药已被证实有心血管获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ef86e461d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270828, encodeId=1eae12e0828f1, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, objectType=article, longId=67351, objectId=ce4c6e35197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce4c6e35197, replyNumber=0, likeNumber=46, createdTime=2016-05-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce4c6e35197, moduleTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce4c6e35197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270827, encodeId=c0c112e082765, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=AIM：降糖药物降低心血管死亡风险各不同二甲双胍效果更好, objectType=article, longId=67043, objectId=08c56e0436b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08c56e0436b, replyNumber=0, likeNumber=59, createdTime=2016-04-24, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08c56e0436b, moduleTitle=AIM：降糖药物降低心血管死亡风险各不同二甲双胍效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08c56e0436b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

降糖药

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：HIV感染 vs 非感染，口服降糖药的有效性研究

2016-09-21

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

十问十答，轻松掌握磺脲类降糖药！

2016-09-16

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

JASN:新型口服降糖药可帮助患者保护肾脏健康

2016-08-25

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

警惕！这些降糖药可引起贫血！

2016-08-24

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

CFDA再次修订警告：这种降糖药可增加心衰风险！

2016-08-17

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

口服降糖药的作用为何越来越差

2016-08-10

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

JAMA：看过来，2型糖尿病降糖药物疗效大PK

2016-07-21

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

重磅！勃林格-礼来降糖药Jardiance在确诊心血管疾病的2型糖尿病患者中显著延缓肾病进展风险

2016-06-22

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制

2016-06-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）

2016-06-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著

2016-06-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平

2016-06-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

降糖药Jardiance缓解肾功能障碍

2016-06-17

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药

2016-05-30

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药

2016-05-30

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

FDA批准强生降糖药INVOKAMET用于2型糖尿病一线治疗

2016-05-28

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

教你搞定「各类口服降糖药」

2016-05-11

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

这4种降糖药已被证实有心血管获益

2016-05-05

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）

2016-05-01

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

AIM：降糖药物降低心血管死亡风险各不同二甲双胍效果更好

2016-04-24

科室
- - 订阅+
  - 更多科室
工具
服务